Memantine in moderate to severe Alzheimer’s disease

被引：2
|
作者：
Andrew Kertesz
机构：
来源：
Current Neurology and Neuroscience Reports | 2003年 / 3卷 / 6期
关键词：
NMDA; Memantine; MMSE Score; NMDA Antagonist; Global Deterioration Scale;
D O I：
10.1007/s11910-003-0051-8
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：485 / 486
页数：1
相关论文
共 50 条
  • [11] Memantine improves independence in moderate to severe Alzheimer's disease
    Guilhaume, C
    Lundbeck, H
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S207 - S208
  • [12] Memantine approved to treat moderate to severe Alzheimer’s disease
    Karen Marder
    [J]. Current Neurology and Neuroscience Reports, 2004, 4 (5) : 349 - 350
  • [13] Memantine enhances autonomy in moderate to severe Alzheimer's disease
    Rive, B
    Vercelletto, M
    Damier, FD
    Cochran, J
    François, C
    [J]. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2004, 19 (05) : 458 - 464
  • [14] Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
    Howard, Robert
    McShane, Rupert
    Lindesay, James
    Ritchie, Craig
    Baldwin, Ashley
    Barber, Robert
    Burns, Alistair
    Dening, Tom
    Findlay, David
    Holmes, Clive
    Hughes, Alan
    Jacoby, Robin
    Jones, Rob
    Jones, Roy
    McKeith, Ian
    Macharouthu, Ajay
    O'Brien, John
    Passmore, Peter
    Sheehan, Bart
    Juszczak, Edmund
    Katona, Cornelius
    Hills, Robert
    Knapp, Martin
    Ballard, Clive
    Brown, Richard
    Banerjee, Sube
    Onions, Caroline
    Griffin, Mary
    Adams, Jessica
    Gray, Richard
    Johnson, Tony
    Bentham, Peter
    Phillips, Patrick
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (10): : 893 - 903
  • [15] Size estimates in the treatment of moderate to severe Alzheimer's disease with memantine
    Vercelletto, M
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S381 - S381
  • [16] Response to memantine treatment in moderate to severe Alzheimer's disease.
    van Dyck, C
    Ferris, S
    Graham, S
    Stoeffler, A
    Olin, J
    Wirth, Y
    Tariot, P
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (04) : S155 - S155
  • [17] Memantine benefits functional abilities in moderate to severe Alzheimer's disease
    Winblad, B.
    Gauthier, S.
    Astrom, D.
    Stender, K.
    [J]. JOURNAL OF NUTRITION HEALTH & AGING, 2010, 14 (09): : 770 - 774
  • [18] Memantine in moderate to severe Alzheimer's disease:: An analysis of individual response
    Ferris, S. H.
    Stoeffler, A.
    Wirth, Y.
    Reisberg, B.
    Moebius, H. J.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 38 - 38
  • [19] Effect of memantine on behavioral outcomes in moderate to severe Alzheimer's disease
    Cummings, JL
    Schneider, E
    Tariot, PN
    Graham, SM
    [J]. NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S127 - S127
  • [20] Is memantine a breakthrough in the treatment of moderate-to-severe Alzheimer's disease?
    Doggrell, S
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (10) : 1857 - 1860
12345